Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2153739
Max Phase: Preclinical
Molecular Formula: C45H42N5O8P
Molecular Weight: 811.83
Molecule Type: Small molecule
Associated Items:
ID: ALA2153739
Max Phase: Preclinical
Molecular Formula: C45H42N5O8P
Molecular Weight: 811.83
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CP(=O)(O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1)c1cc(-c2cccc(Oc3ccccc3)c2)no1
Standard InChI: InChI=1S/C45H42N5O8P/c46-43(51)40(25-33-27-47-38-22-11-10-21-36(33)38)48-44(52)37(41-26-39(50-58-41)32-17-12-20-35(24-32)57-34-18-8-3-9-19-34)29-59(54,55)42(23-30-13-4-1-5-14-30)49-45(53)56-28-31-15-6-2-7-16-31/h1-22,24,26-27,37,40,42,47H,23,25,28-29H2,(H2,46,51)(H,48,52)(H,49,53)(H,54,55)/t37-,40-,42+/m0/s1
Standard InChI Key: SGHHKDAEMQQYOU-CEURZZNXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 811.83 | Molecular Weight (Monoisotopic): 811.2771 | AlogP: 7.68 | #Rotatable Bonds: 17 |
Polar Surface Area: 198.87 | Molecular Species: ACID | HBA: 8 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 1.53 | CX Basic pKa: | CX LogP: 6.28 | CX LogD: 3.90 |
Aromatic Rings: 7 | Heavy Atoms: 59 | QED Weighted: 0.06 | Np Likeness Score: -0.41 |
1. Mucha A, Kafarski P, Berlicki Ł.. (2011) Remarkable potential of the α-aminophosphonate/phosphinate structural motif in medicinal chemistry., 54 (17): [PMID:21780776] [10.1021/jm200587f] |
Source(1):